← Open Payments lookup

ROSEANN BENANTI: Open Payments

NPI 1780330902 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$20,675 in 134 payments from 18 companies in 2025. Trend: 2023 $1,228 · 2024 $1,603 · 2025 $20,675

Speaker / faculty: $15,525Food & beverage: $3,865Travel & lodging: $1,186Education: $99
CompanyPaymentsAmount
Madrigal Pharmaceuticals62$18,832
Janssen Biotech, Inc.18$620
GENZYME CORPORATION2$242
Janssen Scientific Affairs, LLC3$237
ABBVIE INC.14$186
Aimmune Therapeutics, Inc.6$109
Takeda Pharmaceuticals U.S.A., Inc.6$105
Phathom Pharmaceuticals, Inc.7$80
Intercept Pharmaceuticals, Inc.4$67
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$34

Products named: REZDIFFRA, TREMFYA, DUPIXENT, RINVOQ, ZENPEP, VOQUEZNA, OCALIVA, ENTYVIO.

Industry payments across NJ — which companies pay providers there.